A preliminary study of the relation between IL-4 and hypertension in type II diabetes mellitus
暂无分享,去创建一个
[1] A. Andrei,et al. Abdominal Obesity and Type 2 Diabetes Mellitus are Associated With Higher Seric Levels of IL 4 in Adults , 2016, Current health sciences journal.
[2] Gretchen A. Stevens,et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants , 2016, Lancet.
[3] Su-zhan Zhang,et al. Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk , 2014, Cancer Cell International.
[4] J. Youngren,et al. Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain , 2014, PloS one.
[5] M. Banerjee,et al. Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus. , 2014, World journal of diabetes.
[6] N. Morgan,et al. The impact of anti-inflammatory cytokines on the pancreatic β-cell , 2014, Islets.
[7] Milad Mohammadoo-khorasani,et al. Possible Association of IL-4 VNTR Polymorphism with Susceptibility to Preeclampsia , 2014, BioMed research international.
[8] Jaulang Hwang,et al. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis , 2014, Journal of Lipid Research.
[9] F. Mahmoud,et al. Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes , 2013, Disease markers.
[10] Chien-Ning Huang,et al. Association of IL-4 receptor gene polymorphisms with high density lipoprotein cholesterol. , 2012, Cytokine.
[11] M. Shiau,et al. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4 , 2012, International Journal of Obesity.
[12] Chuan‐Mu Chen,et al. Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. , 2010, Metabolism: clinical and experimental.
[13] R. Konwar,et al. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. , 2008, Indian journal of medical sciences.
[14] R. Konwar,et al. E-endocrinology: an update. , 2008, Indian journal of medical sciences.
[15] G. Freund,et al. Type 2 Diabetes Impairs Insulin Receptor Substrate-2-Mediated Phosphatidylinositol 3-Kinase Activity in Primary Macrophages to Induce a State of Cytokine Resistance to IL-4 in Association with Overexpression of Suppressor of Cytokine Signaling-31 , 2007, The Journal of Immunology.
[16] Juliet M Chapman,et al. No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. , 2005, American journal of human genetics.
[17] M. Harada,et al. Association between IL-4 genotype and IL-4 production in the Japanese population , 2002, Genes and Immunity.
[18] L Scola,et al. Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.
[19] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[20] L. Prencipe,et al. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. , 1982, Clinical chemistry.
[21] E. Wong,et al. Kinetic serum creatinine assays. II. A critical evaluation and review. , 1980, Clinical chemistry.
[22] P. Tarli,et al. Simplified enzymic/colorimetric serum urea nitrogen determination. , 1979, Clinical chemistry.
[23] A. Rubenstein,et al. Haemoglobin A1 and diabetes mellitus , 1978, Diabetologia.
[24] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[25] L. Carlson. DETERMINATION OF SERUM TRIGLYCERIDES. , 1963, Journal of atherosclerosis research.
[26] S. Shukla,et al. Association of Genetic Polymorphism of Inflammatory Genes (IL-1β and IL-4) with Diabetes Type 2 , 2015 .
[27] Chien-Ning Huang,et al. Role of Cyotkines in Metabolism and Type 2 Diabetes Mellitus , 2013 .
[28] N. Rifai,et al. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors , 2012 .
[29] W. Paul,et al. The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.
[30] F. Manzato,et al. Determination of high density lipoprotein cholesterol in venous and capillary whole blood. , 1988, Journal of lipid research.